Skip to main content
Top
Published in: Abdominal Radiology 1/2012

01-02-2012

Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-Tesla: preliminary results

Authors: Jeffrey C. Mottola, V. Anik Sahni, Sukru M. Erturk, Richard Swanson, Peter A. Banks, Koenraad J. Mortele

Published in: Abdominal Radiology | Issue 1/2012

Login to get access

Abstract

Purpose

To determine the utility of 3.0-Tesla diffusion-weighted (DW) magnetic resonance imaging (MRI) for focal cystic pancreatic lesion (FCPL) characterization.

Materials and methods

55 FCPL (34 IPMN, 5 serous cystadenoma, and 16 inflammatory) were evaluated. Two radiologists reviewed in consensus DW-MRI images. Reference standard was obtained from patient history, cytological and histopathology data, FCPL fluid analysis, and follow-up imaging results. Signal intensity (SI) and apparent diffusion coefficient values (ADC) of FCPL and normal pancreas were measured. FCPL-to-pancreas SI and ADC ratios were also calculated.

Results

Qualitatively, 11 of 21 non-mucinous vs. 4 of 34 mucinous lesions appeared hyperintense at b value of 1,000 s/mm2 (P = 0.02). Three FCPL demonstrated restricted diffusion: all inflammatory. Significant differences in mean ADC between neoplastic vs. non-neoplastic (P = 0.009), and mucinous vs. non-mucinous (P = 0.013) lesions were demonstrated. FCPL-to-pancreas ADC and SI ratios demonstrated significant differences between neoplastic vs. non-neoplastic lesions [ADC, (P = 0.019); SI for b values 750 (P = 0.010) and 1,000 s/mm2 (P = 0.017)] and mucinous vs. non-mucinous lesions [ADC (P = 0.018); SI for b values 750 (P = 0.013) and 1,000 s/mm2 (P = 0.015)].

Conclusion

Although mean ADC values and FCPL-to-pancreas SI and ADC ratios may be helpful in differentiating FCPL, characterization of individual FCPL by means of 3.0-Tesla DW-MRI appears limited.
Literature
1.
go back to reference Spinelli KS, Fromwiller TE, Daniel RA, et al. (2004) Cystic pancreatic neoplasm: observe or operate. Ann Surg 239:651–657PubMedCrossRef Spinelli KS, Fromwiller TE, Daniel RA, et al. (2004) Cystic pancreatic neoplasm: observe or operate. Ann Surg 239:651–657PubMedCrossRef
2.
go back to reference Allen PJ, Brennan MF (2007) The management of cystic lesions of the pancreas. Adv Surg 41:211–228PubMedCrossRef Allen PJ, Brennan MF (2007) The management of cystic lesions of the pancreas. Adv Surg 41:211–228PubMedCrossRef
3.
go back to reference Lee KS, Sekhar A, Rofsky NM, Pedrosa I (2010) Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol 105:2079–2084PubMedCrossRef Lee KS, Sekhar A, Rofsky NM, Pedrosa I (2010) Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol 105:2079–2084PubMedCrossRef
4.
go back to reference Xhang XM, Mitchell DG, Dohke M, Holland GA, Parker L (2002) Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology 223:547–553CrossRef Xhang XM, Mitchell DG, Dohke M, Holland GA, Parker L (2002) Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology 223:547–553CrossRef
5.
go back to reference Khalid A, Brugge W (2007) ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol 102:2339–2349PubMedCrossRef Khalid A, Brugge W (2007) ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol 102:2339–2349PubMedCrossRef
6.
go back to reference Ferrone CR, Correa-Gallego C, Warshaw AL, et al. (2009) Current trends in pancreatic cystic neoplasms. Arch Surg 144:448–454PubMedCrossRef Ferrone CR, Correa-Gallego C, Warshaw AL, et al. (2009) Current trends in pancreatic cystic neoplasms. Arch Surg 144:448–454PubMedCrossRef
7.
go back to reference Garcea G, Ong SL, Rajesh A, et al. (2008) Cystic lesions of the pancreas. A diagnostic and management dilemma. Pancreatology 8:236–251PubMedCrossRef Garcea G, Ong SL, Rajesh A, et al. (2008) Cystic lesions of the pancreas. A diagnostic and management dilemma. Pancreatology 8:236–251PubMedCrossRef
8.
go back to reference Lopez Hanninen E, Pech M, Rickie J, et al. (2006) Magnetic resonance imaging in the assessment of cystic pancreatic lesions: differentiation of benign and malignant lesion status. Acta Radiol 47:121–129PubMedCrossRef Lopez Hanninen E, Pech M, Rickie J, et al. (2006) Magnetic resonance imaging in the assessment of cystic pancreatic lesions: differentiation of benign and malignant lesion status. Acta Radiol 47:121–129PubMedCrossRef
9.
go back to reference Kim SY, Lee JM, Kim SH, et al. (2006) Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor. AJR Am J Roentgenol 187:1192–1198PubMedCrossRef Kim SY, Lee JM, Kim SH, et al. (2006) Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor. AJR Am J Roentgenol 187:1192–1198PubMedCrossRef
10.
go back to reference Macari M, Finn ME, Bennett GL, et al. (2009) Differentiating pancreatic cystic neoplasms from pancreatic pseudocysts at MR imaging: value of perceived internal debris. Radiology 251:77–84PubMedCrossRef Macari M, Finn ME, Bennett GL, et al. (2009) Differentiating pancreatic cystic neoplasms from pancreatic pseudocysts at MR imaging: value of perceived internal debris. Radiology 251:77–84PubMedCrossRef
11.
go back to reference Curry CA, Eng J, Horton KM, et al. (2000) CT of primary cystic neoplasms: can CT be used for patient and triage? AJR Am J Roentgenol 175:99–103PubMed Curry CA, Eng J, Horton KM, et al. (2000) CT of primary cystic neoplasms: can CT be used for patient and triage? AJR Am J Roentgenol 175:99–103PubMed
12.
go back to reference Sidden CR, Mortele KJ (2007) Cystic tumors of the pancreas: ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MRI 28:339–356CrossRef Sidden CR, Mortele KJ (2007) Cystic tumors of the pancreas: ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MRI 28:339–356CrossRef
13.
go back to reference Parikh T, Drew SJ, Lee VS, et al. (2008) Focal liver lesions detection and characterization with diffusion weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 246:812–822PubMedCrossRef Parikh T, Drew SJ, Lee VS, et al. (2008) Focal liver lesions detection and characterization with diffusion weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 246:812–822PubMedCrossRef
14.
go back to reference Kandpal H, Sharma R, Madhusudhan KS, Kapoor KS (2009) Respiratory-triggered versus breath-hold diffusion-weighted MRI of liver lesions: Comparison of image quality and apparent diffusion coefficient values. AJR Am J Roentgenol 192:915–922PubMedCrossRef Kandpal H, Sharma R, Madhusudhan KS, Kapoor KS (2009) Respiratory-triggered versus breath-hold diffusion-weighted MRI of liver lesions: Comparison of image quality and apparent diffusion coefficient values. AJR Am J Roentgenol 192:915–922PubMedCrossRef
15.
go back to reference Soyer P, Corno L, Boudiaf M, et al. (2010) Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging: comparison with T2-weighted spin-echo MR imaging. Eur J Radiol Soyer P, Corno L, Boudiaf M, et al. (2010) Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging: comparison with T2-weighted spin-echo MR imaging. Eur J Radiol
16.
go back to reference Zhang J, Tehrani YM, Wang L, et al. (2008) Renal masses: characterization with diffusion-weighted MR imaging—a preliminary experience. Radiology 247:458–464PubMedCrossRef Zhang J, Tehrani YM, Wang L, et al. (2008) Renal masses: characterization with diffusion-weighted MR imaging—a preliminary experience. Radiology 247:458–464PubMedCrossRef
17.
go back to reference Kim S, Jain M, Harris AB, et al. (2009) T1 hyperintense renal lesions: characterization with diffusion weighted MR imaging versus contrast-enhanced MR imaging. Radiology 251:796–807PubMedCrossRef Kim S, Jain M, Harris AB, et al. (2009) T1 hyperintense renal lesions: characterization with diffusion weighted MR imaging versus contrast-enhanced MR imaging. Radiology 251:796–807PubMedCrossRef
18.
go back to reference Qayyum A (2009) Diffusion-weighted imaging in the pelvis: concepts and applications. RadioGraphics 29:1797–1810PubMedCrossRef Qayyum A (2009) Diffusion-weighted imaging in the pelvis: concepts and applications. RadioGraphics 29:1797–1810PubMedCrossRef
19.
go back to reference Yamashita Y, Namimoto T, Mitsuzaki K, et al. (1998) Mucin-producing tumor of the pancreas: diagnostic value of diffusion-weighted echo-planar MR imaging. Radiology 208:605–609PubMed Yamashita Y, Namimoto T, Mitsuzaki K, et al. (1998) Mucin-producing tumor of the pancreas: diagnostic value of diffusion-weighted echo-planar MR imaging. Radiology 208:605–609PubMed
20.
go back to reference Inan N, Arslan A, Akansel G, Anik Y, Demerci A (2008) Diffusion-weighted imaging in the differential diagnosis of cystic lesions of the pancreas. AJR Am J Roentgenol 191:1115–1121PubMedCrossRef Inan N, Arslan A, Akansel G, Anik Y, Demerci A (2008) Diffusion-weighted imaging in the differential diagnosis of cystic lesions of the pancreas. AJR Am J Roentgenol 191:1115–1121PubMedCrossRef
21.
go back to reference Boraschi P, Donati F, Gigoni R, Salemi Bartolozzi C, Falaschi F (2010) Diffusion-weighted MRI in the characterization of cystic pancreatic lesions: usefulness of ADC values. Magn Reson Imaging 28:1447–1455PubMedCrossRef Boraschi P, Donati F, Gigoni R, Salemi Bartolozzi C, Falaschi F (2010) Diffusion-weighted MRI in the characterization of cystic pancreatic lesions: usefulness of ADC values. Magn Reson Imaging 28:1447–1455PubMedCrossRef
22.
go back to reference Fatima Z, Ichikawa T, Motosugi U, et al. (2011) Magnetic resonance diffusion-weighted imaging in characterization of pancreatic mucinous cystic lesions. Clin Radiol 66:108–111PubMedCrossRef Fatima Z, Ichikawa T, Motosugi U, et al. (2011) Magnetic resonance diffusion-weighted imaging in characterization of pancreatic mucinous cystic lesions. Clin Radiol 66:108–111PubMedCrossRef
23.
go back to reference Irie H, Honda H, Kuroiwa T, et al. (2002) Measurement of the apparent diffusion coefficient in intraductal mucin-producing tumor of the pancreas by diffusion-weighted echo-planar MR imaging. Abdom Imaging 27:82–87PubMedCrossRef Irie H, Honda H, Kuroiwa T, et al. (2002) Measurement of the apparent diffusion coefficient in intraductal mucin-producing tumor of the pancreas by diffusion-weighted echo-planar MR imaging. Abdom Imaging 27:82–87PubMedCrossRef
24.
go back to reference Chang KJ, Kamel IR, Macura KJ, Bluemke DA (2008) 3.0-T MR imaging of the abdomen: comparison with 1.5-T. Radiographics 28:1983–1998PubMedCrossRef Chang KJ, Kamel IR, Macura KJ, Bluemke DA (2008) 3.0-T MR imaging of the abdomen: comparison with 1.5-T. Radiographics 28:1983–1998PubMedCrossRef
25.
go back to reference Notohamiprodjo M, Dietrich O, Horger W, et al. (2010) Diffusion tensor imaging (DTI) of the kidney at 3 Tesla–feasibility, protocol evaluation and comparison to 1.5 Tesla. Investig Radiol 45:245–254CrossRef Notohamiprodjo M, Dietrich O, Horger W, et al. (2010) Diffusion tensor imaging (DTI) of the kidney at 3 Tesla–feasibility, protocol evaluation and comparison to 1.5 Tesla. Investig Radiol 45:245–254CrossRef
26.
go back to reference Kuhl CK, Textor J, Gieseke J, et al. (1995) Acute and sub-acute ischemic stroke at high field strength (3.0-T) diffusion-weighted MR imaging: intraindividual comparative study. Radiology 234:509–516CrossRef Kuhl CK, Textor J, Gieseke J, et al. (1995) Acute and sub-acute ischemic stroke at high field strength (3.0-T) diffusion-weighted MR imaging: intraindividual comparative study. Radiology 234:509–516CrossRef
27.
go back to reference Rosenkrantz AB, Oei M, Babb JS, Niver BE, Taouli B (2011) Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging 33:128–135PubMedCrossRef Rosenkrantz AB, Oei M, Babb JS, Niver BE, Taouli B (2011) Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging 33:128–135PubMedCrossRef
28.
go back to reference Nam SJ, Hwang HK, Kim H, et al. (2010) Lymphoepithelial cysts in the pancreas: MRI of two cases with emphasis of diffusion-weighted imaging characteristics. J Magn Reson Imaging 32:692–696PubMedCrossRef Nam SJ, Hwang HK, Kim H, et al. (2010) Lymphoepithelial cysts in the pancreas: MRI of two cases with emphasis of diffusion-weighted imaging characteristics. J Magn Reson Imaging 32:692–696PubMedCrossRef
Metadata
Title
Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-Tesla: preliminary results
Authors
Jeffrey C. Mottola
V. Anik Sahni
Sukru M. Erturk
Richard Swanson
Peter A. Banks
Koenraad J. Mortele
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 1/2012
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9737-6

Other articles of this Issue 1/2012

Abdominal Radiology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine